A patient has died from kidney injury in a trial of ’ lead antibody-drug conjugate, although the biotech has been advised to ...

Strong field is shaping up for the latest edition of the Amgen Irish Open as Rasmus Hojgaard seeks to defend his title next ...

The countdown is on for the 2025 Amgen Irish Open, returning to The K Club’s Palmer North Course from September 4–7, with the ...

Amgen Inc. recently surpassed earnings expectations, achieving an impressive $6.02 EPS this quarter. Amgen's revenue also saw ...

Famous LIV Golf faces Brooks Koepka, Sergio Garcia and Tyrell Hatton will compete in the Amgen Irish Open at the K Club next ...

Clinical trial tech outfit Medidata has elevated a new strategy leader from within. | Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa ...

Amgen Inc. has witnessed a notable reduction in stock holdings by Donoghue Forlines LLC, slicing 17.6% to stand at 4,656 ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint.

Amgen AMGN delivered yet another strong quarterly performance. Its second-quarter 2025 earnings and sales beat estimates. The ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.